Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 250-178-0 | CAS number: 30399-84-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 282.105 mg/m³
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 25
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
DNEL related information
Local effects
Acute/short term exposure
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 200 mg/kg bw/day
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 20
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
DNEL related information
Workers - Hazard for the eyes
Additional information - workers
Long-term exposure - systemic effects
Dermal
Two long-term studies were available, from which a DNEL value can be derived:
In a 90-day oral toxicity study performed in rats with fatty acids, C18-unsaturated, dimers (CAS No. 61788-89-4), the NOAEL for systemic toxicity was 741 and 855 mg/kg bw/day for males and females, respectively.
In a Two-Generation Reproduction Toxicity Study with tall oil fatty acids (CAS No. 61790-12-3), the oral NOAEL for both systemic and reproductive effects was 10% test material in diet, corresponding to approximate doses of 4000 and 5000 mg/kg bw/day for males and females, respectively.
On the basis of structure analogy (monomeric vs. dimeric fatty acids) and study duration, the reproduction toxicity study was considered more adequate for DNEL derivation of the monomeric members of the chemical category. Based on sensitivity, the NOAEL value of 4000 mg/kg bw/day for male rats was selected as relevant dose descriptor.
For the dermal exposure route, the dose descriptor is converted into a corrected starting point by route-to route extrapolation.
Due to their physicochemical properties, the skin penetration potential of monomeric fatty acids (isooctadecanoic acid, CAS No. 30399-84-9; octadecanoic acid, branched and linear, CAS No. 68201-37-6; C16-C18 and C18-unsaturated, branched and linear, CAS No. 68955-98-6) is expected to be very low. Penetration of the stratum corneum is facilitated by high lipophilicity, but because of the low solubility in water, transfer into the epidermis and hence dermal uptake is likely to be low.
Taking this information into account, along with the weight of evidence that monomeric C16 and C18 fatty acids are negligibly absorbed through human (in vitro) and rat skin (in vitro and in vivo) (Howes, 1975), absorption through human skin in vivo is considered to be not significant. In terms of the assessment of systemic long-term effects upon dermal exposure, a dermal absorption of 20% of the oral absorption was assumed as a worst case scenario. Thus, a modification factor of 0.2 was applied for correction of differences between dermal and oral absorption, yielding a dermal NAEL of 20000 mg/kg bw/day.
The DNEL for long-term effects is derived by applying an assessment factor (AF) for allometric scaling of 4, an interspecies AF of 2.5, an intraspecies (human) AF of 5 for worker, and an additional AF of 2 to account for exposure duration (extrapolation subchronic – chronic). This results in a total AF of 100. Applying this total AF to the dermal NAEL mentioned above, results in a DNEL for dermal long-term effects of 200 mg/kg bw/day. Taking into account the modification factor for differences between oral and dermal absorption, the overall AF is 20 (0.2 x 100).
The following table summarises the DNEL calculation steps and applied modification/assessment factors.
Step 1) Relevant dose descriptor |
NOAEL(oral, rat) = 4000 mg/kg bw/day |
Step 2) Modification of starting point |
0.2 |
Step 3) Assessment factors |
|
DNEL value |
200 mg/kg bw/day |
Inhalation
For the inhalative exposure route, the dose descriptor mentioned above (NOAEL = 4000 mg/kg bw/day) should be converted into a corrected starting point by route-to route extrapolation.
The dose descriptor is converted into an inhalatory NAEC (in mg/m³) first by using an 8 h standard respiratory volume of 0.38 m³/kg bw for the rat. Additionally, differences between oral and inhalative absorption should be taken into account. Based on physicochemical properties and toxicokinetic information, absorption through epithelial barriers is generally expected to be low. In view of the fact that for (dietary) fatty acids of lower molecular weight oral absorption is facilitated by fluids present in the gastrointestinal but not in the respiratory tract, absorption through the lung epithelium is not expected to be higher than through the intestinal epithelium. Therefore, for the oral-to-inhalation extrapolation, a factor of 1 (no difference in absorption) is included and considered to sufficiently account for differences in oral and inhalative absorption. Finally, a further modification factor of 0.67 is applied to account for differences in 8 h inhalative volumes between workers in rest (6.7 m³) and workers under light activity (10 m³). This results in an inhalatory NAEC of 7052.6 mg/m³/day.
The DNEL for long-term exposure is derived by applying an assessment factor (AF) for remaining interspecies differences of 2.5, an intraspecies (human) AF of 5 for worker, and an additional AF of 2 to account for exposure duration (extrapolation subchronic – chronic). This results in a total AF of 25. Applying this total AF to the inhalatory NAEC mentioned above, results in an inhalation DNEL for systemic effects after long-term exposure of 282.105 mg/m³.
The following table summarises the DNEL calculation steps and applied modification/assessment factors.
Step 1) Relevant dosedescriptor |
NOAEL(oral, rat) = 4000 mg/kg bw/day |
Step 2) Modification of starting point Correction for differences between dermal and oral absorption Correction for differences in 8-h inhalative volumes between workers in rest and workers under light activity |
0.38 m³/kg bw
1
6.7 m³/10 m³ |
Step 3) Assessment factors |
|
DNEL value |
282.105 mg/m³ |
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 69.565 mg/m³
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 50
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
DNEL related information
Local effects
Acute/short term exposure
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 100 mg/kg bw/day
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 40
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
DNEL related information
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 20 mg/kg bw/day
- Most sensitive endpoint:
- effect on fertility
DNEL related information
- Overall assessment factor (AF):
- 200
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
DNEL related information
General Population - Hazard for the eyes
Additional information - General Population
Long-term exposure - systemic effects
Dermal
Two long-term studies were available, from which a DNEL value can be derived:
In a 90-day oral toxicity study performed in rats with fatty acids, C18-unsaturated, dimers (CAS No. 61788-89-4), the NOAEL for systemic toxicity was 741 and 855 mg/kg bw/day for males and females, respectively.
In a Two-Generation Reproduction Toxicity Study with tall oil fatty acids (CAS No. 61790-12-3), the oral NOAEL for both systemic and reproductive effects was 10% test material in diet, corresponding to approximate doses of 4000 and 5000 mg/kg bw/day for males and females, respectively.
On the basis of structure analogy (monomeric vs. dimeric fatty acids) and study duration, the reproduction toxicity study was considered more adequate for DNEL derivation of the monomeric members of the chemical category. Based on sensitivity, the NOAEL value of 4000 mg/kg bw/day for male rats was selected as relevant dose descriptor.
For the dermal exposure route, the dose descriptor is converted into a corrected starting point by route-to route extrapolation.
Due to their physicochemical properties, the skin penetration potential of monomeric fatty acids (isooctadecanoic acid, CAS No. 30399-84-9; octadecanoic acid, branched and linear, CAS No. 68201-37-6; C16-C18 and C18-unsaturated, branched and linear, CAS No. 68955-98-6) is expected to be very low. Penetration of the stratum corneum is facilitated by high lipophilicity, but because of the low solubility in water, transfer into the epidermis and hence dermal uptake is likely to be low.
Taking this information into account, along with the weight of evidence that monomeric C16 and C18 fatty acids are negligibly absorbed through human (in vitro) and rat skin (in vitro and in vivo) (Howes, 1975), the absorption of fatty acids, C18-unsaturated, dimers through human skin in vivo is considered to be not significant. In terms of the assessment of systemic long-term effects upon dermal exposure, a dermal absorption of 20% of the oral absorption was assumed as a worst case scenario. Thus, a modification factor of 0.2 was applied for correction of differences between dermal and oral absorption, yielding a dermal NAEL of 20000 mg/kg bw/day.
The DNEL for long-term effects is derived by applying an assessment factor (AF) for allometric scaling of 4, an interspecies AF of 2.5, an intraspecies (human) AF of 10 for the general population, and an additional AF of 2 to account for exposure duration (extrapolation subchronic – chronic). This results in a total AF of 200. Applying this total AF to the dermal NAEL mentioned above, results in a DNEL for dermal long-term effects of 100 mg/kg bw/day. Taking into account the modification factor for differences between oral and dermal absorption, the overall AF is 40 (0.2 x 200).
The following table summarises the DNEL calculation steps and applied modification/assessment factors.
Step 1) Relevant dose descriptor |
NOAEL(oral, rat) = 4000 mg/kg bw/day |
Step 2) Modification of starting point |
0.2 |
Step 3) Assessment factors |
|
DNEL value |
100 mg/kg bw/day |
Inhalation
For the inhalative exposure route, the dose descriptor mentioned above (NOAEL = 4000 mg/kg bw/day) should be converted into a corrected starting point by route-to route extrapolation.
The dose descriptor is converted into an inhalatory NAEC (in mg/m³) first by using a 24 h standard respiratory volume of 1.15 m³/kg bw for the rat. Additionally, differences between oral and inhalative absorption should be taken into account. Based on physicochemical properties and toxicokinetic information, absorption through epithelial barriers is generally expected to be low. In view of the fact that for (dietary) fatty acids of lower molecular weight oral absorption is facilitated by fluids present in the gastrointestinal but not in the respiratory tract, absorption through the lung epithelium is not expected to be higher than through the intestinal epithelium. Therefore, for the oral-to-inhalation extrapolation, a factor of 1 (no difference in absorption) is included and considered to sufficiently account for differences in oral and inhalative absorption. This results in an inhalatory NAEC of 3478.3 mg/m³/day.
The DNEL for long-term exposure is derived by applying an assessment factor (AF) for remaining interspecies differences of 2.5, an intraspecies (human) AF of 10 for the general population, and an additional AF of 2 to account for exposure duration (extrapolation subchronic – chronic). This results in a total AF of 50. Applying this total AF to the inhalatory NAEC mentioned above, results in an inhalation DNEL for systemic effects after long-term exposure of 69.565 mg/m³.
The following table summarises the DNEL calculation steps and applied modification/assessment factors.
Step 1) Relevant dose descriptor |
NOAEL(oral, rat) = 4000 mg/kg bw/day |
Step 2) Modification of starting point Correction for differences between dermal and oral absorption |
1.15 m³/kg bw
1 |
Step 3) Assessment factors |
|
DNEL value |
69.565 mg/m³ |
Oral
For the oral exposure route, the same bioavailability for experimental animals and humans is assumed as a worst case. Therefore, no further modifications of the dose descriptor are necessary, corresponding to a modification factor of 1 to account for differences in oral absorption between rats and humans.
The DNEL for long-term effects is derived by applying an assessment factor (AF) for allometric scaling of 4, an interspecies AF of 2.5, an intraspecies (human) AF of 10 for the general population, and an additional AF of 2 to account for exposure duration (extrapolation subchronic – chronic). This results in a total AF of 200. Applying this total AF to the oral NOAEL mentioned above, results in a DNEL for oral long-term effects of 20 mg/kg bw/day.
The following table summarises the DNEL calculation steps and applied modification/assessment factors.
Step 1) Relevant dose descriptor |
NOAEL(oral, rat) = 4000 mg/kg bw/day |
Step 2) Modification of starting point |
1 |
Step 3) Assessment factors |
|
DNEL value |
20 mg/kg bw/day |
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.